An In vitro dimerization assay for the adverse outcome pathway approach in risk assessment of human estrogen receptor α-mediated endocrine-disrupting chemicals
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, S.-H. | - |
dc.contributor.author | Seo, H. | - |
dc.contributor.author | Seo, H. | - |
dc.contributor.author | Lazari, M. | - |
dc.contributor.author | D'Agostino, M. | - |
dc.contributor.author | Byrd, N. | - |
dc.contributor.author | Yoon, K.S. | - |
dc.contributor.author | Lee, H.-S. | - |
dc.contributor.author | Park, Y. | - |
dc.date.accessioned | 2023-03-08T08:35:43Z | - |
dc.date.available | 2023-03-08T08:35:43Z | - |
dc.date.issued | 2022-03 | - |
dc.identifier.issn | 0045-6535 | - |
dc.identifier.issn | 1879-1298 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/61610 | - |
dc.description.abstract | The adverse outcome pathway (AOP) has been recently proposed as an effective framework for chemical risk assessment. The AOP framework offers the advantage of effectively integrating individual in vitro studies and in silico prediction models. Thus, the development of an effective testing method to measure key events caused by chemicals is essential for chemical risk assessment through a fully developed AOP framework. We developed a human cell-based estrogen receptor α (ERα) dimerization assay using the bioluminescence resonance energy transfer (BRET) technique and evaluated the ERα dimerization activities of 72 chemicals. Fifty-one chemicals were identified to mediate dimerization of ERα, and the BRET-based ERα dimerization assay could effectively measure the events that mediated dimerization of ERα by the estrogenic chemicals. These results were compared with the results of pre-existing assay to determine whether the BRET-based ERα dimerization assay could be employed as an in vitro test method to provide scientific information for explaining key events as a part of the AOP framework. Consequently, we propose that the BRET-based ERα dimerization assay is suitable for measuring the chemical-mediated dimerization of ERα, a key event in the AOP framework for cellular-level risk assessment of estrogenic chemicals. © 2021 Elsevier Ltd | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | Elsevier Ltd | - |
dc.title | An In vitro dimerization assay for the adverse outcome pathway approach in risk assessment of human estrogen receptor α-mediated endocrine-disrupting chemicals | - |
dc.type | Article | - |
dc.identifier.doi | 10.1016/j.chemosphere.2021.133267 | - |
dc.identifier.bibliographicCitation | Chemosphere, v.290 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.wosid | 000753975700002 | - |
dc.identifier.scopusid | 2-s2.0-85121137855 | - |
dc.citation.title | Chemosphere | - |
dc.citation.volume | 290 | - |
dc.type.docType | Article | - |
dc.publisher.location | 영국 | - |
dc.subject.keywordAuthor | Adverse outcome pathway (AOP) | - |
dc.subject.keywordAuthor | Bioluminescence resonance energy transfer (BRET) | - |
dc.subject.keywordAuthor | Chemical risk assessment | - |
dc.subject.keywordAuthor | Estrogen receptor α (ERα) | - |
dc.subject.keywordAuthor | In vitro dimerization assay | - |
dc.relation.journalResearchArea | Environmental Sciences & Ecology | - |
dc.relation.journalWebOfScienceCategory | Environmental Sciences | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194
COPYRIGHT 2019 Chung-Ang University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.